MedPath

Testosterone Cypionate

Testosterone Cypionate Injection, USP

Approved
Approval ID

4bc98c02-6f63-440e-b3ce-89682ade81f6

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 24, 2020

Manufacturers
FDA

A-S Medication Solutions

DUNS: 830016429

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Testosterone Cypionate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50090-4921
Application NumberANDA091244
Product Classification
M
Marketing Category
C73584
G
Generic Name
Testosterone Cypionate
Product Specifications
Route of AdministrationINTRAMUSCULAR
Effective DateMarch 26, 2019
FDA Product Classification

INGREDIENTS (4)

TESTOSTERONE CYPIONATEActive
Quantity: 200 mg in 1 mL
Code: M0XW1UBI14
Classification: ACTIB
BENZYL BENZOATEInactive
Quantity: 0.2 mL in 1 mL
Code: N863NB338G
Classification: IACT
COTTONSEED OILInactive
Quantity: 560 mg in 1 mL
Code: H3E878020N
Classification: IACT
BENZYL ALCOHOLInactive
Quantity: 9.45 mg in 1 mL
Code: LKG8494WBH
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Testosterone Cypionate - FDA Drug Approval Details